(+)-pilocarpine decreases response to substance ISO RGD:731358 6480464 BDKRB1 protein mutant form results in decreased susceptibility to Pilocarpine CTD PMID:15196965 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:730874 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BDKRB1 mRNA CTD PMID:22079256 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of BDKRB1 mRNA CTD PMID:30723492 15-acetyldeoxynivalenol increases expression ISO RGD:730874 6480464 15-acetyldeoxynivalenol results in increased expression of BDKRB1 mRNA CTD PMID:23792671 17beta-estradiol affects expression ISO RGD:731358 6480464 Estradiol affects the expression of BDKRB1 mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO RGD:730874 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of BDKRB1 mRNA CTD PMID:17404688 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:730874 6480464 Tetrachlorodibenzodioxin affects the expression of BDKRB1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BDKRB1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BDKRB1 mRNA CTD PMID:22298810 3',5'-cyclic GMP multiple interactions EXP 6480464 [bradykinin, Leu(8)-des-Arg(9)- results in decreased activity of BDKRB1 protein] inhibits the reaction [Valsartan results in increased abundance of Cyclic GMP] CTD PMID:16982965 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:730874 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BDKRB1 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:730874 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BDKRB1 mRNA CTD PMID:28628672 8-Br-cAMP increases expression ISO RGD:730874 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BDKRB1 mRNA CTD PMID:20147733 [des-Arg(9)]-bradykinin increases expression ISO RGD:731358 6480464 bradykinin, des-Arg(9)- results in increased expression of BDKRB1 protein CTD PMID:16039549 [des-Arg(9)]-bradykinin multiple interactions ISO RGD:731358 6480464 lipopolysaccharide A promotes the reaction [bradykinin more ... CTD PMID:16039549 Ac-Ser-Asp-Lys-Pro-OH multiple interactions ISO RGD:731358 6480464 [BDKRB1 protein affects the activity of ACE protein] which affects the hydrolysis of goralatide CTD PMID:20096676 Ac-Ser-Asp-Lys-Pro-OH affects abundance ISO RGD:731358 6480464 BDKRB1 protein affects the abundance of goralatide CTD PMID:20096676 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of BDKRB1 protein CTD PMID:29165388 aldehydo-D-glucose multiple interactions EXP 6480464 argan oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein], Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein] CTD PMID:29165388 all-trans-retinoic acid increases expression ISO RGD:730874 6480464 Tretinoin results in increased expression of BDKRB1 mRNA CTD PMID:23830798 AM-251 multiple interactions ISO RGD:730874 6480464 AM 251 inhibits the reaction [anandamide results in decreased activity of BDKRB1 protein] CTD PMID:19022239 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BDKRB1 mRNA CTD PMID:16483693 anandamide multiple interactions ISO RGD:730874 6480464 AM 251 inhibits the reaction [anandamide results in decreased activity of BDKRB1 protein] CTD PMID:19022239 anandamide decreases activity ISO RGD:730874 6480464 anandamide results in decreased activity of BDKRB1 protein CTD PMID:19022239 antirheumatic drug decreases expression ISO RGD:730874 6480464 Antirheumatic Agents results in decreased expression of BDKRB1 mRNA CTD PMID:24449571 arsenite(3-) decreases expression ISO RGD:730874 6480464 arsenite results in decreased expression of BDKRB1 mRNA CTD PMID:23974009 beclomethasone decreases expression ISO RGD:730874 6480464 Beclomethasone results in decreased expression of BDKRB1 mRNA CTD PMID:18039523 benzo[a]pyrene affects methylation ISO RGD:730874 6480464 Benzo(a)pyrene affects the methylation of BDKRB1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:730874 6480464 Benzo(a)pyrene results in increased methylation of BDKRB1 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO RGD:730874 6480464 7 more ... CTD PMID:20382639 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BDKRB1 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:730874 6480464 bisphenol A results in decreased methylation of BDKRB1 gene CTD PMID:31601247 bisphenol A decreases methylation ISO RGD:731358 6480464 bisphenol A results in decreased methylation of BDKRB1 promoter CTD PMID:27312807 bisphenol A multiple interactions ISO RGD:730874 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of BDKRB1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BDKRB1 mRNA CTD PMID:28628672 , PMID:31601247 calcitriol increases expression ISO RGD:730874 6480464 Calcitriol results in increased expression of BDKRB1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:730874 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of BDKRB1 mRNA CTD PMID:21592394 calcium atom multiple interactions ISO RGD:730874 6480464 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [[kallidin more ... CTD PMID:15703175 calcium atom multiple interactions EXP 6480464 [kallidin more ... CTD PMID:22554775 calcium(0) multiple interactions ISO RGD:730874 6480464 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [[kallidin more ... CTD PMID:15703175 calcium(0) multiple interactions EXP 6480464 [kallidin more ... CTD PMID:22554775 capsaicin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Capsaicin results in increased expression of BDKRB1 mRNA] more ... CTD PMID:22264228 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of BDKRB1 mRNA CTD PMID:22264228 capsazepine multiple interactions EXP 6480464 capsazepine inhibits the reaction [Capsaicin results in increased expression of BDKRB1 mRNA] CTD PMID:22264228 carbon nanotube increases expression ISO RGD:731358 6480464 Nanotubes more ... CTD PMID:25554681 ceruletide increases expression ISO RGD:731358 6480464 Ceruletide results in increased expression of BDKRB1 mRNA CTD PMID:21484880 CGP 52608 multiple interactions ISO RGD:730874 6480464 CGP 52608 promotes the reaction [RORA protein binds to BDKRB1 gene] CTD PMID:28238834 chlorpyrifos increases expression ISO RGD:731358 6480464 Chlorpyrifos results in increased expression of BDKRB1 mRNA CTD PMID:32715474 chromium(6+) decreases expression ISO RGD:730874 6480464 chromium hexavalent ion results in decreased expression of BDKRB1 mRNA CTD PMID:30690063 cisplatin increases expression ISO RGD:731358 6480464 Cisplatin results in increased expression of BDKRB1 protein CTD PMID:31874189 corn oil multiple interactions EXP 6480464 Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein] CTD PMID:29165388 crocidolite asbestos decreases expression ISO RGD:730874 6480464 Asbestos, Crocidolite results in decreased expression of BDKRB1 mRNA CTD PMID:24160326 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of BDKRB1 mRNA CTD PMID:10498854 , PMID:15576455 D-glucose increases expression EXP 6480464 Glucose results in increased expression of BDKRB1 protein CTD PMID:29165388 D-glucose multiple interactions EXP 6480464 argan oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein], Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein] CTD PMID:29165388 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [KNG1 protein binds to and results in increased activity of BDKRB1 protein] CTD PMID:11159707 dexamethasone multiple interactions ISO RGD:730874 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BDKRB1 mRNA more ... CTD PMID:28628672 dexamethasone decreases expression ISO RGD:730874 6480464 Dexamethasone results in decreased expression of BDKRB1 mRNA CTD PMID:25047013 dexamethasone phosphate multiple interactions ISO RGD:730874 6480464 dexamethasone 21-phosphate inhibits the reaction [IL1B protein promotes the reaction [kallidin more ... CTD PMID:17931716 dextran sulfate multiple interactions ISO RGD:731358 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BDKRB1 mRNA CTD PMID:29950665 dioxygen multiple interactions ISO RGD:731358 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BDKRB1 mRNA CTD PMID:30529165 doxorubicin multiple interactions ISO RGD:731358 6480464 BDKRB1 protein affects the reaction [Doxorubicin results in decreased expression of BCL2 protein] more ... CTD PMID:18627295 enalapril increases expression EXP 6480464 Enalapril results in increased expression of BDKRB1 mRNA CTD PMID:18796534 enalapril multiple interactions EXP 6480464 [kallidin, des-Arg(10)- results in decreased activity of BDKRB1 protein] which results in decreased susceptibility to Enalapril CTD PMID:21430409 enalaprilat dihydrate increases activity ISO RGD:730874 6480464 Enalaprilat results in increased activity of BDKRB1 protein CTD PMID:11880373 enalaprilat dihydrate multiple interactions ISO RGD:730874 6480464 bradykinin more ... CTD PMID:11880373 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of BDKRB1 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:731358 6480464 epoxiconazole results in decreased expression of BDKRB1 mRNA CTD PMID:35436446 fulvestrant multiple interactions ISO RGD:730874 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of BDKRB1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of BDKRB1 mRNA CTD PMID:27387713 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BDKRB1 mRNA CTD PMID:33387578 glucose increases expression EXP 6480464 Glucose results in increased expression of BDKRB1 protein CTD PMID:29165388 glucose multiple interactions EXP 6480464 argan oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein], Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein] CTD PMID:29165388 goralatide affects abundance ISO RGD:731358 6480464 BDKRB1 protein affects the abundance of goralatide CTD PMID:20096676 goralatide multiple interactions ISO RGD:731358 6480464 [BDKRB1 protein affects the activity of ACE protein] which affects the hydrolysis of goralatide CTD PMID:20096676 hydrochlorothiazide decreases expression EXP 6480464 Hydrochlorothiazide results in decreased expression of BDKRB1 mRNA CTD PMID:18796534 indometacin multiple interactions EXP 6480464 Indomethacin inhibits the reaction [[kallidin, des-Arg(10)- binds to and results in increased activity of BDKRB1 protein] which results in increased abundance of Calcium] CTD PMID:22554775 indometacin multiple interactions ISO RGD:730874 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BDKRB1 mRNA more ... CTD PMID:28628672 ketamine increases expression ISO RGD:731358 6480464 Ketamine results in increased expression of BDKRB1 mRNA, Ketamine results in increased expression of BDKRB1 protein CTD PMID:27638051 lipopolysaccharide affects response to substance ISO RGD:731358 6480464 BDKRB1 protein affects the susceptibility to Lipopolysaccharides CTD PMID:20096676 lipopolysaccharide increases expression ISO RGD:731358 6480464 Lipopolysaccharides results in increased expression of BDKRB1 mRNA CTD PMID:29775649 lipopolysaccharide affects expression EXP 6480464 Lipopolysaccharides affects the expression of BDKRB1 protein CTD PMID:29775649 lipopolysaccharide multiple interactions EXP 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased expression of BDKRB1 protein] CTD PMID:29775649 lipopolysaccharide increases expression ISO RGD:730874 6480464 Lipopolysaccharides results in increased expression of BDKRB1 mRNA CTD PMID:29775649 , PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:730874 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of BDKRB1 protein] more ... CTD PMID:29775649 , PMID:35811015 LY294002 multiple interactions ISO RGD:730874 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IL1A protein results in increased expression of BDKRB1 protein], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of BDKRB1 protein] CTD PMID:29775649 medroxyprogesterone acetate decreases expression ISO RGD:730874 6480464 Medroxyprogesterone Acetate results in decreased expression of BDKRB1 mRNA CTD PMID:20843944 meloxicam multiple interactions EXP 6480464 meloxicam inhibits the reaction [KNG1 protein binds to and results in increased activity of BDKRB1 protein] CTD PMID:11159707 Methanandamide decreases activity ISO RGD:730874 6480464 methanandamide results in decreased activity of BDKRB1 protein CTD PMID:19022239 Mitotane increases activity EXP 6480464 Mitotane results in increased activity of BDKRB1 protein CTD PMID:11159707 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Capsaicin results in increased expression of BDKRB1 mRNA] CTD PMID:22264228 paracetamol affects expression ISO RGD:731358 6480464 Acetaminophen affects the expression of BDKRB1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BDKRB1 mRNA CTD PMID:33387578 perindopril affects expression EXP 6480464 Perindopril affects the expression of BDKRB1 protein CTD PMID:18806609 phenobarbital increases expression ISO RGD:730874 6480464 Phenobarbital results in increased expression of BDKRB1 mRNA CTD PMID:19084549 potassium chromate multiple interactions ISO RGD:730874 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BDKRB1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:730874 6480464 potassium chromate(VI) results in decreased expression of BDKRB1 mRNA CTD PMID:22079256 , PMID:22714537 progesterone multiple interactions ISO RGD:730874 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of BDKRB1 mRNA CTD PMID:17404688 progesterone decreases expression ISO RGD:730874 6480464 Progesterone results in decreased expression of BDKRB1 mRNA CTD PMID:17404688 more ... quercitrin decreases expression ISO RGD:730874 6480464 quercitrin results in decreased expression of BDKRB1 mRNA CTD PMID:25193878 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:730874 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BDKRB1 mRNA CTD PMID:35811015 serpentine asbestos decreases expression ISO RGD:730874 6480464 Asbestos, Serpentine results in decreased expression of BDKRB1 mRNA CTD PMID:24160326 silicon dioxide decreases expression ISO RGD:730874 6480464 Silicon Dioxide analog results in decreased expression of BDKRB1 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:730874 6480464 Silicon Dioxide results in increased expression of BDKRB1 mRNA CTD PMID:25351596 silver atom decreases expression ISO RGD:731358 6480464 Silver results in decreased expression of BDKRB1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:731358 6480464 Silver results in decreased expression of BDKRB1 mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:730874 6480464 sodium arsenite results in increased expression of BDKRB1 mRNA CTD PMID:34032870 sodium atom multiple interactions ISO RGD:730874 6480464 Sodium affects the reaction [[kallidin, des-Arg(10)- results in increased activity of BDKRB1 protein] which results in increased abundance of Calcium] CTD PMID:15703175 streptozocin multiple interactions EXP 6480464 [HOE 140, desArg(10)- binds to and results in decreased activity of BDKRB1 protein] which results in decreased susceptibility to Streptozocin CTD PMID:17989505 streptozocin increases expression ISO RGD:731358 6480464 Streptozocin results in increased expression of BDKRB1 mRNA CTD PMID:19516248 temozolomide decreases expression ISO RGD:730874 6480464 Temozolomide results in decreased expression of BDKRB1 mRNA CTD PMID:31758290 testosterone multiple interactions ISO RGD:730874 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of BDKRB1 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:730874 6480464 Testosterone results in decreased expression of BDKRB1 mRNA CTD PMID:21592394 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of BDKRB1 mRNA CTD PMID:16644059 tetrachloromethane multiple interactions ISO RGD:731358 6480464 PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of BDKRB1 mRNA] CTD PMID:18038451 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BDKRB1 protein CTD PMID:18054572 thalidomide multiple interactions ISO RGD:731358 6480464 Thalidomide inhibits the reaction [bradykinin, des-Arg(9)- results in increased expression of BDKRB1 protein] CTD PMID:16039549 titanium dioxide multiple interactions ISO RGD:731358 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BDKRB1 mRNA CTD PMID:29950665 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of BDKRB1 mRNA CTD PMID:31129395 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BDKRB1 mRNA CTD PMID:33387578 triclosan increases expression ISO RGD:730874 6480464 Triclosan results in increased expression of BDKRB1 mRNA CTD PMID:30510588 valsartan multiple interactions EXP 6480464 [bradykinin more ... CTD PMID:16982965 vincristine multiple interactions EXP 6480464 [HOE 140, desArg(10)- binds to and results in decreased activity of BDKRB1 protein] which results in decreased susceptibility to Vincristine CTD PMID:17989505 zinc atom multiple interactions ISO RGD:730874 6480464 Zinc affects the reaction [Enalaprilat results in increased activity of BDKRB1 protein] CTD PMID:11880373 zinc atom affects binding ISO RGD:730874 6480464 Zinc binds to BDKRB1 protein CTD PMID:11880373 zinc(0) multiple interactions ISO RGD:730874 6480464 Zinc affects the reaction [Enalaprilat results in increased activity of BDKRB1 protein] CTD PMID:11880373 zinc(0) affects binding ISO RGD:730874 6480464 Zinc binds to BDKRB1 protein CTD PMID:11880373
